HIGHLIGHTS
- who: Max J. M. Silvis and colleagues from the Department of Cardiology, University Medical Center Utrecht, GA Utrecht, The Netherlands have published the Article: NLRP3-Inflammasome Inhibition with IZD334 Does Not Reduce Cardiac Damage in a Pig Model of Myocardial Infarction, in the Journal: Biomedicines 2022, 3056 of /2022/
- what: The aim of this study was to investigate the effects of the inhibitor IZD334 on cardiac damage in a pig model of myocardial infarction. In the current study, the authors assessed inflammasome inhibition in_vitro and hypothesized that NLRP3-inflammasome inhibition with IZD334 reduces IS and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.